From the janssenlabels product insert:
"
Metastatic castration-resistant prostate cancer:
• ZYTIGA 1,000 mg orally once daily with prednisone 5 mg orally twice daily. (2.1)
Metastatic castration-sensitive prostate cancer:
• ZYTIGA 1,000 mg orally once daily with prednisone 5 mg orally once daily. (2.2)
"
I am trying to understand the logic behind why the dosage would be different based on resistance status. why does crpc need a higher glucocorticoid replacement therapy.
I understand 5 mg was the dose used for hspc in the clinical trials so i am wondering why they choose a lower does when conducting the trial.